Cargando…
Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal
Chemoembolization for hepatocellular carcinoma (HCC) is often suboptimal due to multiple involved signaling and lack of effective drugs. Arsenic trioxide (ATO) is a potent chemotherapeutic agent, which can target multiple signaling and have substantial efficacy on HCC. However, its usage is limited...
Autores principales: | Kong, Degang, Jiang, Tao, Liu, Jian, Jiang, Xinyi, Liu, Bei, Lou, Cheng, Zhao, Baobing, Carroll, Steven L., Feng, Gong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738295/ https://www.ncbi.nlm.nih.gov/pubmed/33307843 http://dx.doi.org/10.1080/10717544.2020.1856219 |
Ejemplares similares
-
Efficacy and Safety of the Arsenic Trioxide/Lipiodol Emulsion in the Transcatheter Arterial Chemoembolization Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma
por: Li, Zhaonan, et al.
Publicado: (2021) -
The antitumor effect of arsenic trioxide on hepatocellular carcinoma is enhanced by andrographolide
por: Duan, Xuhua, et al.
Publicado: (2017) -
Hepatic Arterial Chemoembolization With Arsenic Trioxide Eluting CalliSpheres Microspheres Versus Lipiodol Emulsion: Pharmacokinetics And Intratumoral Concentration In A Rabbit Liver Tumor Model
por: Duan, Xu-hua, et al.
Publicado: (2019) -
Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma
por: Lu, Wei, et al.
Publicado: (2017) -
Parthenolide and arsenic trioxide co-trigger autophagy-accompanied apoptosis in hepatocellular carcinoma cells
por: Yi, Juan, et al.
Publicado: (2022)